Tradestie Institutional Equity Comparison Engine

ECOR vs ATHE โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-19 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

ECOR Overall Edge

ECOR Captures Institutional Edge (2โ€“0 Pillars ยท 5โ€“3 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to electroCore, Inc. Common Stock (ECOR) driven by superior Growth & Margin, Momentum & Technical. Fundamentally, ECOR trades at N/M Forward P/E with -33.1% operating margin (+11.5% YoY revenue) versus ATHE at N/M Forward P/E and -695.1% operating margin (-79.0% YoY). In options structure, ECOR sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro) against ATHE sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro).

Valuation Winner Tie
ECOR N/M vs ATHE N/M Fwd P/E
Growth & Margin Winner ECOR
Op Margin -33.1% vs -695.1% ยท YoY +11.5% vs -79.0%
Momentum & Technical Winner ECOR
1Y -4.0% vs -54.0% ยท 52W Pos 6% vs 3%
Options & Structure Winner Tie
UNCLASSIFIED (N/A IV) vs UNCLASSIFIED (N/A IV)
ECOR NASDAQ
electroCore, Inc. Common Stock
Electromedical & Electrotherapeutic Apparatus
$4.85
-6.19% 1D
Market Cap $47.7M
1M Return -34.01%
1Y Return -3.96%
Forward P/E N/M
Unified AI Score
56.8 / 100 HOLD
Tech 68.0 Fund 53.0 Flow 50.0 Mom 64.0
ATHE NASDAQ
Alterity Therapeutics Limited American Depositary Shares
Pharmaceutical Preparations
$1.66
-2.65% 1D
Market Cap $32.5M
1M Return -30.75%
1Y Return -54.03%
Forward P/E N/M
Unified AI Score
39.2 / 100 SELL
Tech 25.0 Fund 42.0 Flow 50.0 Mom 55.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: ECOR -3.96% ATHE -54.03% Spread: +50.07 pp (ECOR Lead)

Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant Revenue ($B) & Operating Margin (%)
ECOR TTM Op. Margin: -33.1% ATHE TTM Op. Margin: -695.1%
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on ECOR vs ATHE. Trailing 12-month operating profitability (ECOR -33.1% vs ATHE -695.1%) and valuation multiples (ECOR N/M vs ATHE N/M Forward P/E) are benchmarked directly in Pillar 4 below.

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: ECOR (5) vs ATHE (3)
Institutional Metric ECOR ATHE Criterion Row Winner
Market Capitalization Scale $47.7M $32.5M Larger Scale ECOR
Trailing P/E Ratio Valuation N/M N/M Lower Multiple Tie
Forward P/E Ratio Valuation N/M N/M Lower Multiple Tie
Revenue Growth (YoY) Growth +11.5% -79.0% Higher Growth ECOR
Operating Margin (TTM) Profitability -33.1% -695.1% Higher Margin ECOR
Net Profit Margin Profitability -33.5% 0.0% Higher Margin ATHE
Return on Equity (ROE) Capital Efficiency -478.7% -55.0% Higher ROE ATHE
52-Week Range Position Momentum 6% ($4โ€“$13) 3% ($2โ€“$6) Stronger Trend ECOR
Beta / 30D Volatility Risk Regime 1.52ฮฒ ยท 155% Vol 1.05ฮฒ ยท 102% Vol Lower Realized Risk ATHE
Unified Institutional Score Composite Signal 56.8 / 100 (HOLD) 39.2 / 100 (SELL) Higher Composite ECOR

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full ECOR vs ATHE Buy Guide
ECOR UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile N/A
IV Regime Unclassified
Live ECOR Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
ATHE UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile N/A
IV Regime Unclassified
Live ATHE Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither ECOR nor ATHE registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.